Multipotent progenitor cells confirm their T cell-lineage identity in the CD4 -CD8double-negative (DN) pro-T cell DN2 stages, when expression of the essential transcription factor Bcl11b begins. In vivo and in vitro stage-specific deletions globally identified Bcl11b-controlled target genes in pro-T cells. Proteomics analysis revealed that Bcl11b associated with multiple cofactors and that its direct action was needed to recruit those cofactors to selective target sites. Regions near functionally regulated target genes showed enrichment for those sites of Bcl11b-dependent recruitment of cofactors, and deletion of individual cofactors relieved the repression of many genes normally repressed by Bcl11b. Runx1 collaborated with Bcl11b most frequently for both activation and repression. In parallel, Bcl11b indirectly regulated a subset of target genes by a gene network circuit via the transcription inhibitor Id2 (encoded by Id2) and transcription factor PLZF (encoded by Zbtb16); Id2 and Zbtb16 were directly repressed by Bcl11b, and Id2 and PLZF controlled distinct alternative programs. Thus, our study defines the molecular basis of direct and indirect Bcl11b actions that promote T cell identity and block alternative potentials.
T he zinc-finger transcription factor Bcl11b is required for the development of α β T cells and most γ δ T cells [1] [2] [3] . Its expression initiates precisely during commitment to the T cell lineage 4 ; that is, before expression of the T cell antigen receptor and between the CD4 -CD8double-negative (DN) pro-T cell stages DN2a (CD25 + CD44 + c-Kit hi+ ) and DN2b (CD25 + CD44 + c-Kit + ). Progression through commitment to the T cell lineage is blocked or highly abnormal in cells that lack Bcl11b 5-7 . Bcl11b-deficient pro-T cells are less sensitive to Notch signaling and more prone to differentiate into natural killer (NK) cells than are their wildtype counterparts 6, 8 . They also fail to go through β -selection, due to defects in T cell gene expression as well as to abnormal persistence of immature features, including expression of the surface marker c-Kit [5] [6] [7] [8] [9] . Deletion of Bcl11b after β -selection causes abnormal activation of genes encoding effector molecules 10, 11 and multiple functional defects in later thymocytes and mature T cells [12] [13] [14] . While the importance of Bcl11b in T cell development is clear, its exact mechanism of action is not. Bcl11b can bind to GC-rich sequences in DNA 15 and can recruit chromatin-modifying NuRD and SIRT1 complexes 16, 17 , but in pro-T cells it binds mainly to sites in open chromatin showing enrichment for motifs for Ets and Runx transcription factors 7, 18 . Published work has linked Bcl11b to both activation and repression 5, 6, 8, 10, 12, 19, 20 , with its most consistent effects across development on a core of genes that apparently require repression by Bcl11b in T cells 7, 11 . Finally, Bcl11b's effects have striking overlap with the effects of the basic helix-loop-helix (bHLH) transcription factor E2A in early T cells 7 , yet the basis for this convergence is not known.
This report addresses three questions about Bcl11b's roles in establishing T cell commitment. First, what are the target genes directly regulated by Bcl11b during T cell commitment? Second, what are the mechanisms that Bcl11b deploys to work as an activator or a repressor at its target sites? We identify direct target loci on the basis of a new criterion for functional sites of Bcl11b action, through its role in recruiting specific cofactors. Finally, how many of the effects of Bcl11b are indirect, and how are they mediated? We show that Bcl11b in pro-T cells blocked expression of the E-protein antagonist Id2 (encoded by Id2) and the innate-response regulator PLZF (encoded by Zbtb16). Id2-mediated suppression of E-protein activity is important for all innate lymphoid cells, including NK cells [21] [22] [23] [24] [25] [26] , while PLZF is crucial for innate-type T cells and for non-cytolytic innate lymphoid cells 24, [27] [28] [29] [30] [31] , and both govern subsets of myeloid and dendritic cells [32] [33] [34] . We find that a gene network that relates Id2 and Zbtb16 to Bcl11b's function sheds light on the split between the T cell and innate immune cell families of developmental programs.
Results

Impacts of Bcl11b on gene expression in thymocytes at
DN2-DN3 stages. Bcl11b regulates a distinct set of target genes during the initial T cell-lineage commitment of fetal-liver-derived precursor cells differentiating in vitro, including many targets that seem to be unique to this developmental period 7 . To investigate its role during commitment in vivo, we compared DN pro-T cells in mice in which loxP-flanked Bcl11b alleles (Bcl11b fl/fl ) were conditionally deleted by Cre recombinase, before or after commitment. For the first we used Cre recombinase expressed in all hematopoietic cells via the hematopoietic compartment-specific gene Vav1 (Vav1-iCre) 35 ; for the second we used Cre expressed via the proximal promoter of the gene encoding the tyrosine kinase Lck (Lck-Cre), from a transgene 36 that is first activated in DN2 pro-T cells ( Fig. 1a and Supplementary  Fig. 1a ). The mice also had a Cre-dependent reporter for the expression of yellow fluorescent protein (YFP) from a ubiquitously expressed locus (ROSA26R-YFP), which distinguished cells in which the alleles were deleted from those in which they were not (normal DN2a cells). In mice with wild-type Bcl11b, Vav1-iCre caused all DN thymocytes
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Genes downregulated in Bcl11b-KO cells at stages DN2 and DN3 (Bcl11b-dependent genes)
Genes with significantly differential expression, relative to that in wild-type cells, in all three of the following conditions: Lck-Cre-mediated deletion of Bcl11b in vivo, Vav1-iCre-mediated deletion of Bcl11b in vivo, and Cas9-mediated deletion of Bcl11b in DN2b-DN3 cells differentiated in vitro from BM-derived precursor cells (expression values, Supplementary Tables 1 and 2) ; genes listed in alphabetical order here (complete list of genes in each comparison, Supplementary Table 3 ).
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to express YFP ( Fig. 1a, left) , whereas Lck-Cre activated YFP only in cells at the DN2b stage and later ( Fig. 1a and Supplementary  Fig. 1a ). Thus, Lck-Cre deleted genes only after Bcl11b would normally be turned on 4 . Homozygous Bcl11b fl/fl mice bred to express either of these Cre-encoding transgenes showed arrest of the T cell precursors with a c-Kit hi+ CD25 + phenotype that resembled normal DN2a cells (Fig. 1a ). In the Lck-Cre + Bcl11b fl/fl mice, however, the c-Kit hi+ DN2a-like cells comprised two populations: a YFP -CD44 + population enriched for true DN2a cells, and a much larger YFP + CD44 lo population generated only after deletion of Bcl11b ( Supplementary Fig. 1a,b ). Thus, excision of Bcl11b was able to generate the YFP + c-Kit hi+ CD25 + phenotype through retrograde-like differentiation from cells that had previously reached DN2b stage after activating Bcl11b initially.
The gene-expression patterns in DN thymocytes from mice with Bcl11b deleted by either Vav1-iCre or Lck-Cre showed that about 300 genes were reproducibly upregulated in YFP + DN2-like thymocytes homozygous for knockout of Bcl11b as compared to their expression in YFP + DN2 and DN3 thymocytes with wild-type Bcl11b or heterozygous knockout of Bcl11b (control cells) ( Fig. 1b) ; this defined the genes normally repressed by Bcl11b. About 220 genes were significantly downregulated in these Bcl11b-knockout cells ( Fig. 1c ), which defined genes dependent on Bcl11b. These criteria (a false-discovery rate (FDR) of < 0.05, an increase or decrease in expression of > 2-fold (referred to as |log 2 FC| > 1), and average reads per kilobase million (RPKM) of > 1; Supplementary Tables 1  and 2 ...
Deletion of Bcl11b
Deletion of Bcl11b Table 5 ). c, Gene-ontology analysis of molecules that interact with Bcl11b, showing the top ten gene-ontology (GO) terms (left) and the enrichment for those terms in those complexes relative to their abundance in the mouse genome (middle left column). d, Bcl11brepressor complexes detected by liquid chromatography and tandem mass spectrometry; magenta indicates cofactors discussed in detail in Results. e, Immunoblot analysis (IB) of total extracts of Scid.adh.2c2 cells as in b (above lanes) after immunoprecipitation with monoclonal antibody to Flag (IP: anti-Flag; left) or of nuclear lysates of such cells without immunoprecipitation (right), probed with antibodies to (anti-) components of the complexes in d (indicated along right margin); gels cropped to focus on protein species migrating near the mobilities of the size markers (left margin). Data are representative of two independent experiments (b,e).
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NaTuRe IMMuNoLogy cells resembled normal DN2a thymocytes, their gene-expression patterns distinguished the mutant cells from any normal Bcl11b +/+ cell subsets. Highly robust effects were seen in multiple samples; for example, for Bcl11b itself, for Zbtb16 and Id2 (both repressed by Bcl11b) and for Cd6 (a Bcl11b-dependent gene encoding the surface receptor CD6) ( Supplementary Fig. 2 ). Interestingly, certain DEGs also showed partial de-repression in YFP + cells heterozygous for knockout of Bcl11b ( Fig. 1b and Supplementary Table 1 ). At a subset of the loci identified above, the effects of deletion of Bcl11b before commitment (via Vav1-iCre) were more severe than the effects of deletion after commitment (via Lck-Cre), and Vav1-iCre-mediated deletion had more severe effects on total thymus cellularity ( Supplementary Fig. 1c ). About 40 Bcl11b-dependent genes failed to be turned on in cells in which Bcl11b was deleted via Vav1-iCre ('Vav1-iCre-knockout cells') but were expressed somewhat in cells in which Bcl11b was deleted via Lck-Cre ('Lck-Creknockout cells') ( Fig. 1d ), while ~ 85 targets repressed by Bcl11b were overexpressed more in the Vav1-iCre-knockout cells than in the Lck-Cre-knockout cells (Fig. 1e ). This difference suggested that even transient Bcl11b expression in the Lck-Cre deletion model provided some function needed for T-cell development. The most timing-sensitive genes included Cd3g, Cd3d, Cd3e and Dntt, among the Bcl11b-dependent genes, and Pou2af1, Tyrobp, Cd7, Itgae, Itgb7, Klf2, Trpm1, Cd163l1 (Scart1), Cited4 and Tnni1 (genes associated with progenitors, γ δ T cells and alternative lineages), among genes repressed by Bcl11b. However, most DEGs required Bcl11b both during commitment and continuously after commitment, for activation or especially for repression in pro-T cells.
For mechanistic experiments assessing Bcl11b function, we also acutely disrupted Bcl11b via the endonuclease Cas9 in pro-T cells differentiating in vitro and defined the genes affected by this ( Supplementary Fig. 3a and Supplementary Table 2 ). Bone marrow (BM) precursor cells from C57BL/6 (B6) mice with expression of Cas9 via ROSA26 and transgenic expression of the anti-apoptotic protein Bcl2 (B6.ROSA26-Cas9;Bcl2-tg; called 'Cas9-Bcl2 cells' here) were cultured for 7 d on OP9-DL1 stroma (OP9 mouse BM stromal cells expressing the DL1 ligand for Notch signaling receptors), then were transduced with retroviral vector encoding small guide RNA (sgRNA) targeting Bcl11b and, 7 d later, were harvested for analysis by RNA-based next-generation sequencing (RNA-seq). Most of these genes also overlapped the significant DEGs both in cells with deletion via Lck-Cre and those with deletion via Vav1-iCre in vivo ( Supplementary Fig. 3b and Supplementary Table 3 ). The significant DEGs in all three ( Table 1 ) included most of the targets previously reported in fetal liver-derived pro-T cells 7 ( Supplementary  Fig. 3c ). Notably, the transcription factor-encoding genes Id2 and Zbtb16 were highly significant targets of repression by Bcl11b in DN2-DN3 cells in every case. Thus, during pro-T cell commitment, Bcl11b activated and repressed several hundred genes encoding molecules important for T cell identity.
A challenge of functional specificity. To determine which genes were directly regulated by Bcl11b, we analyzed Bcl11b by chromatin immunoprecipitation followed by deep sequencing (ChIP-seq). However, despite the prevalence of repressive effects of Bcl11b, binding of Bcl11b across the genome seemed to occur mainly at open chromatin sites with active marks 7,18 globally associated with active genes and showed no distinction between unregulated loci and those with any response to deletion of Bcl11b ( Supplementary  Fig. 4a and Supplementary Table 2 ). We investigated whether distinct motifs were bound at functional sites. Most sites bound by Bcl11b in DN3 pro-T cells show enrichment for Ets and Runx motifs 7, 18 ; we compared those with GC-rich sequences originally reported as a cognate site 15 and with three newly reported motifs for the binding of Bcl11b to protein-binding microarrays 37 . While matches to the newly defined sites (log odds ≥ 5) were found at 10-18% of sites occupied by Bcl11b, DEGs did not show enrichment for those matches (Supplementary Table 4 ). Genomic regions near DEGs actually showed substantial depletion of Bcl11b-binding sites in CpG islands ( Supplementary Fig. 4b ). Bcl11b occupancy and target-site motifs were thus insufficient to distinguish sites of Bcl11b function.
Bcl11b interacts with several 'repressor' complexes.
We reasoned that the sites at which Bcl11b exerts regulatory functions could be identified through its local interactions with specific protein factors. To identify the functional components of Bcl11b complexes that control gene expression in pro-T cells, we transduced Scid.adh.2c2 cells, which are a DN3-like cell line 38, 39 (Fig. 2a) , with Myc-and Flag-tagged Bcl11b, then subjected the Bcl11b-containing protein complexes to two-step affinity purification followed by SDS-PAGE and silver staining ( Fig. 2b) . Analysis by liquid chromatography and tandem mass spectrometry identified more than 300 molecules for which the complexes showed supra-threshold enrichment, based on mass spectrometry (MASCOT) enrichment scores (Supplementary Table 5 ). The complexes showed considerable enrichment for the bifunctional transcription factor Runx1 and proteins annotated as being involved in 'negative regulation of gene expression' , 'transcriptional regulation' and 'chromatin remodeling' (Fig. 2c ). Bcl11b's ChIP 
10 0 10 1 10 2 10 3 10 4 10 5 ResouRce NaTuRe IMMuNoLogy interaction partners for which the complexes showed the greatest enrichment included multiple members of the NuRD ('nucleosome-remodeling deacetylase') histone-deacetylase complex, Rest ('RE-1-silencing transcription factor') transcriptional repressor complex (also known as the NRSF ('neuron-restrictive silencer factor') complex), and the Kdm1a histone deactylase-recruitment complex (also known as the LSD1 ('lysine-specific demethylase 1') complex), with lower but still substantial scores for the Polycomb repressor complex PRC1, in confirmation of published evidence of a Bcl11b-NuRD association 16 (Fig. 2d ). The association of major components of those complexes (Chd4, Mta2, Rnf2 (Ring1b), Rest, LSD1 and Hdac2) with Bcl11b was confirmed by co-immunoprecipitation ( Fig. 2e ). Bcl11b has also been found in SWI/SNF chromatin-remodeling complexes 40 , and the complexes also showed specific enrichment for the SWI/SNF component Smarca4 (Brg1) (Supplementary Table 5 ) but not most other SWI/SNF components. We note that although LSD1, Chd4, Mta2 and Ring1b act as components of repressor complexes, in specific contexts they too are reported to contribute to gene activation [41] [42] [43] [44] [45] . Thus, both 'repressor complexes' and Runx1 might serve roles in Bcl11b-mediated positive or negative regulation of genes.
Identification of Bcl11b-dependent cofactor-binding sites.
To determine whether the differential gene expression in primary pro-T cells was linked to genomic regions at which specific cofactor assemblies might be nucleated by Bcl11b, we performed ChIPseq analysis of wild-type pro-T cells and those in which Bcl11b was deleted. To obtain the large number of cells needed, we used in vitro differentiation cultures with deletion of Bcl11b fl/fl effected by activation of the tamoxifen-inducible Cre-ERT2 construct by 4-OH tamoxifen (4-OHT) ( Supplementary Fig. 4c ). On day 7, before treatment with 4-OHT, most cells showed a DN2a-DN2b phenotype (Lin -CD45 + c-Kit + CD25 + ; Supplementary Fig. 4d ). At 5 d after removal of 4-OHT, Cre-ERT2-expressing control cells with wild-type Bcl11b had efficiently progressed to a c-Kit lo DN3 stage, while Bcl11b-deficient cells were still characteristically c-Kit hi+ ( Fig. 3a and Supplementary Fig. 4e ). ChIP-seq analysis identified more than 25,000 reproducible Bcl11b peaks in Bcl11b +/+ Cre-ERT2 (control) DN3 cells (including 82% of peaks previously reported in B6 DN3 cells without 4-OHT treatment 7 ; Supplementary Fig. 4f ), and these peaks almost completely disappeared from cells in which Bcl11b was deleted ( Fig. 3b ). Of the factors assessed, only Brg1 could not be mapped through the use of commercially available reagents (data not shown). In the control cells, Chd4, Mta2, Rest, Ring1b, LSD1 and Runx1 each bound at from ~6,500 sites (Rest) to ~33,000 sites (Runx1). Those peaks overlapped Bcl11b peaks to different extents (Fig. 3c ). However, the results clearly showed that distinct subsets of peaks for each cofactor depended on the presence of Bcl11b for their recruitment. Deletion of Bcl11b caused large fractions of some cofactor peaks to disappear (Mta2 and Rest) or relocate (Chd4, Ring1b, LSD1 and Runx1) ( Fig. 3c ). In each case, most of the Bcl11b-dependent peaks coincided with sites bound by Bcl11b in wild-type cells (Fig. 3c ), which indicated that binding of Bcl11b itself was needed to recruit that cofactor to such sites. The number of Mta2 peaks was especially sharply reduced by deletion of Bcl11b, although the abundance of Mta2 protein in Bcl11b-deficient cells was comparable to that in wild-type DN3 cells ( Supplementary  Fig. 4g ); this suggested that most of its genome-wide associations in these cells depended on Bcl11b.
Only a small subset of Bcl11b sites showed Bcl11b-dependent binding of cofactors, among the tens of thousands of Bcl11b peaks across the genome. Some of the genes repressed by Bcl11b not only had Bcl11b-dependent cofactor peaks ( Fig. 4a-d ) but also showed newly generated cofactor peaks that occupied distinct sites when Bcl11b was deleted (Fig. 4a,b ). Motif 'preference' for cofactor binding changed when Bcl11b was absent. Bcl11b-dependent cofactor peaks genome-wide showed considerable enrichment for motifs not only for the Ets and Runx families but also for the bHLH family of transcription factors ( Supplementary Fig. 5a,b) . A minority of these sites included the motifs defined by protein-binding microarrays 37 , similar to Bcl11b sites overall ( Supplementary Table 4 ). However, the 'new' cofactor peaks that appeared specifically when Bcl11b was deleted had sharply altered motif distributions, with bHLH motifs ('E2A' or 'Ptf1a') being much less common and motifs for the bZIP and HMG families of transcription factors and other motifs more commonly showing enrichment ( Supplementary Fig. 5c ). Bcl11b at CpG islands overlapped mainly sites at which Chd4, Ring1b, LSD1 or Runx1 was engaged whether Bcl11b was deleted or not ( Supplementary Fig. 5d ). Thus, Bcl11b both facilitated the binding of cofactors to a subset of sites occupied by Bcl11b and antagonized the binding of cofactors to other sites.
Bcl11b alters cofactor binding at functional target loci. Bcl11bdependent cofactor peaks were found around genes that Bcl11b repressed 7 (Fig. 4a-d) , both in primary DN3 cells and in Scid. adh.2c2 cells ( Supplementary Fig. 6a-d) . For Id2, Bcl11b-dependent cofactor peaks were seen not on the gene body itself but substantially upstream and downstream of the Id2 locus ( Fig. 4a , Supplementary Fig. 6a ), consistent with the extended regulatory system for this gene 22 . Similarly, for Zbtb16 and Tnni1, only one of several sites seemed to be Bcl11b dependent, and for Cd163l1, the various cofactors varied in Bcl11b dependence at different sites ( Fig. 4b-d and Supplementary Fig. 6b-d ), which suggested that Bcl11b might interact separately with distinct complex subcomponents. Finally, selective Bcl11b-dependent recruitment of cofactors was also seen at genes that were positively regulated by Bcl11b in pro-T cells, such as the Cd3gde cluster and Cd6 ( Supplementary Fig.  6e,f) . The bifunctional transcription factor Runx1 was frequently recruited to Bcl11b sites around all classes of targets. Thus, the binding of Bcl11b recruited different cofactors to specific subsets of its genomic sites, including both positively regulated loci and negatively regulated loci.
Statistical evidence indicated that the co-recruitment identified above was functionally relevant. In contrast to results obtained for the simple binding of Bcl11b itself, sites of Bcl11b-dependent recruitment of cofactors were found to be enriched at Bcl11b-regulated loci (defined in Supplementary Fig. 4a and Supplementary Table 2 ). Among the DEGs linked to direct binding of Bcl11b, Bcl11bdependent cofactor peaks and 'new' cofactor peaks that appeared only when Bcl11b was deleted were considerably over-represented, relative to their representation among genes that also had Bcl11b binding but did not change expression when Bcl11b was deleted (Fig. 4e,f) . Target genes normally repressed by Bcl11b showed particular enrichment for Bcl11b-dependent recruitment of Runx1 (Fig. 4e ), while they showed depletion for Bcl11b-dependent recruitment of Rest. Mta2 accompanied the binding of Bcl11b at DEGs and non-DEGs alike, but targets repressed by Bcl11b showed significant enrichment for Bcl11b-dependent recruitment of Chd4, Ring1b and LSD1 (Fig. 4e ). As expected for mediators of repression, these sites had minimal association with the active histone mark H3K27Ac. At sites linked to Bcl11b-dependent DEGs (Fig. 4e ), there was also highly significant enrichment for Bcl11b-dependent recruitment of Runx1, Chd4, LSD1 and Ring1b, but with substantial enrichment for H3K27Ac as well. Interestingly, DEGs normally repressed by Bcl11b showed the most specific enrichment for 'new' cofactor peaks (Chd4, Ring1b, LSD1, Runx1 and Ring1b) that appeared only when Bcl11b was absent, as H3K27Ac marking of these genes also increased in cells in which in Bcl11b was deleted (Fig. 4f ). Although Supplementary Fig. 11a ; representative flow cytometry data, Supplementary Fig. 11d ). *P < 0.05 and **P < 0.01 (two-sided Student's t-test). b, Experimental test for cell autonomy of altered differentiation by cells in which Bcl11b was disrupted with or without disruption of Id2 or Zbtb16 (experimental plan, Supplementary Fig. 12a ). Flow cytometry of primary DN cells derived from BM precursor cells after culture for 7 d on OP9-DL1 stroma, then split into three aliquots separately transduced with sgRNA targeting the various gene combinations to be tested (left margin) (all detected with a CFP reporter), or with sgRNA targeting Bcl11b alone, with a human nerve growth factor receptor (hNGFR) marker (sgBcl11b/hNGFR), as a reference standard, or with empty vector plus green fluorescent protein (Mock/GFP), as a control. For each experimental comparison, the three populations were then pooled (left margin) 3 d after infection, transferred to OP9-Mig stroma and cultured for 4 d. Results show forward scatter (FSC) versus the expression of Lin, NK1.1 or CD11c in CFP + , hNGFR + or GFP + cells (above plots). Numbers below outlined areas indicate percent cells in each. c,d, Important roles for Id2 and PLZF in establishing the phenotypes of Bcl11b-deficient pro-T cells: effects on alternative-lineage markers (c) and on specific genes ResouRce NaTuRe IMMuNoLogy context of both recruitment and inhibition of recruitment, was a much stronger predictor of Bcl11b functionality at genomic sites than was Bcl11b binding alone.
Gene repression is complex, and it is not known how many binding sites are usually needed for effective repression of a target by Bcl11b. However, we investigated whether Bcl11b-dependent corecruitment could identify sites that exerted particularly strong effects in repression. We designed sgRNAs to disrupt either of two sites flanking Id2 ( Supplementary Fig. 7a ) or one site downstream of Tnni1 (Fig. 4c) in Scid.adh.2c2 cells and tested the cells in which these sites had been disrupted for deregulation of the target gene. Through the use of transduction of Cas9 plus sgRNA followed by cloning, we identified cells in which the target sites were completely disrupted, as shown by genomic qPCR (Supplementary Fig. 7b,c) . Loss of the Tnni1 candidate silencer site 'Sil + 14k' elevated Tnni1 expression at least fivefold (P = 9.52 × 10 -6 (two-sided Student's t-test); Supplementary Fig. 7c ). Deletion of one Id2 candidate site ('Sil + 40k') consistently raised Id2 expression in the Scid.adh.2c2 cells above background, despite the presence of numerous other Bcl11b sites around the locus (P = 9.49 × 10 -4 (two-sided Student's t-test)); however, deletion of another Id2 candidate site ('Sil -600k') did not ( Supplementary Fig. 7a ). Thus, Bcl11b-dependent recruitment of cofactors helped in identifying functional repression sites in the genome.
Functional effect of cofactors on the activities of Bcl11b.
Recruitment of the cofactors themselves contributed functionally to Bcl11b's effects, as shown when we compared the effects of acute disruption of Bcl11b with those of the disruption of the genes encoding the cofactors. We generated sgRNAs directed against coding regions for Chd4, Mta1-Mta2, Rest, Ring1a-Ring1b, LSD1 or Runx1, each with a cyan fluorescent protein (CFP) reporter, and confirmed that these eliminated expression of the target protein in Cas9-transduced Scid.adh.2c2 cells 46 ( Supplementary Fig. 8a ). We then transduced those into Cas9-Bcl2 primary cells, in parallel with sgRNA directed against Bcl11b alone or control sgRNA ( Supplementary Fig. 3a) , to compare their effects directly during in vitro T cell development. At the time of transduction, after 7 d of culture on OP9-DL1 stromal cells, most of the Cas9-Bcl2 primary cells were at a DN2 stage (c-Kit + CD25 + ; Supplementary Fig. 8b ). After 7 more days, transduced (CFP + ) control cells ( Supplementary Fig. 8c ) had progressed into the DN3 stage ( Fig. 5a ), whereas cells transduced with Bcl11b-specific sgRNA showed the typical c-Kit hi+ DN2a-like phenotype. The effects of cofactor deletion on surface phenotype were milder than those of Bcl11b deletion (Fig. 5a ), although RNA transcript structures confirmed the biallelic deletions at the targeted sites in the loci encoding these cofactors ( Supplementary Fig. 8d ).
Cofactor deletion specifically affected RNA expression, more frequently for genes regulated by Bcl11b that were directly bound by Bcl11b (|log 2 FC| > 1; Fig. 5b-d and Supplementary Table 6 ) than for 'background' genes expressed independently of Bcl11b (|log 2 FC| < 0.5), at substantial levels in cells transduced with control sgRNA (RPKM > 3), and without scorable binding of Bcl11b (Fig. 5b, right) . Most genes repressed by Bcl11b that were directly bound by Bcl11b were also de-repressed after deletion of at least one of the cofactors (Fig. 5b, left) , indicative of distinct gene-specific patterns of cofactor response. Among Bcl11b-dependent targets, many were downregulated after deletion of Mta1, Mta2 or Runx1 (Fig. 5b, middle) . As summarized (Fig. 5c,d) , deletion of Mta1, Mta2 or Runx1 caused the largest number of significant changes in gene expression (adjusted P value, < 0.1 (EdgeR); Supplementary  Table 6 ) among both Bcl11b-repressed genes and Bcl11b-dependent genes, and these effects were concordant with the effects of the deletion of Bcl11b for 80-90% of genes significantly regulated by Runx1 and ~ 90% of genes significantly regulated by Mta1 and Mta2. Thus, cofactor recruitment was functionally significant but with targetgene-specific functional requirements.
Cofactor recruitment by Bcl11b in marking of the loci encoding
TCRβ and TCRγ. Bcl11b-deficient mice can generate T cells of the γ δ lineage but not those of the α β lineage, associated with a failure of rearrangement of the β -chain variable region and diversity-joining regions (V β -DJ β ) of the T cell antigen receptor (TCR) 1, 3, 6, 9, 10 . In BM-derived pro-T cells developing in vitro, Bcl11b and Runx1 cooccupied multiple sites across both the complex encoding the TCR β -chain (Tcrb) and the complex encoding the TCR γ -chain (Tcrg). However, these genomic regions differed considerably in the extent to which their binding of Runx1 depended on Bcl11b ( Supplementary  Fig. 9 ). Whereas the binding of Runx1 across the V β -encoding segments was highly dependent on Bcl11b ( Supplementary Fig. 9a ), its binding across the whole Tcrg complex was largely independent of Bcl11b ( Supplementary Fig. 9b) . Notably, the difference between these loci was not revealed by differential RNA expression, as the pro-T cells cultured in vitro to this early DN3-like stage still showed minimal transcription of genes encoding V β regions, with or without Bcl11b ( Supplementary Fig. 9a ). Instead, the difference in the Bcl11b-dependent recruitment of cofactors might indicate locusspecific roles in establishing permissive chromosome structure 18 that could underlie later effects of Bcl11b on DNA rearrangement.
Id2 and Zbtb16 in the Bcl11b gene-regulatory network. The direct effects of the binding of Bcl11b defined above left open the possibility that the effects of Bcl11b on gene expression in pro-T cells could include indirect effects as well. Genes encoding the transcription factors Id2 and PLZF, which promote development of innate lymphoid cells, including NK cells 24, 28, 47, 48 , were always upregulated in Bcl11b-deficient pro-T cells 6, 7 (Table 1 and Supplementary  Tables 1-3 ). The E2A antagonist Id2 was of particular interest, for the effects of knocking out Bcl11b in fetal liver-derived pro-T cells 7 show a surprisingly large overlap with the effects of knocking out Tcf3 (which encodes E2A) 49 . Whereas the enrichment for bHLH motifs (for Ptf1a or E2A) at Bcl11b sites for the recruitment of cofactors ( Supplementary Fig. 5b ) suggested possible formation of Bcl11b-E2A complexes, this was not supported by the ChIP data: only 104 of 1,430 published E2A-occupied peaks in DN3 cells 50 overlapped any of the ~ 26,000 Bcl11b peaks. This raised the possibility that repression of an intermediate regulator such as Id2 might contribute to the effects of Bcl11b on gene expression.
To assess the roles of Id2 and PLZF in Bcl11b-deficient cells, we carried out single-and double-deletion experiments. Cas9-Bcl2 BM precursor cells were co-transduced with sgRNA targeting Bcl11b and/or Id2 or Zbtb16, singly or in combination (method as in Supplementary Fig. 3a ). Id2 and Zbtb16 both showed increased expression in Bcl11b-deficient cells (compared to that in control cells without deletion), but Id2 did not in cells with double knockout (DKO) of Bcl11b and Id2 (Bcl11b-Id2-DKO cells) and Zbtb16 did not in cells with double knockout of Bcl11b and Zbtb16 (Bcl11b-Zbtb16-DKO cells), respectively ( Supplementary Fig. 10 ). While the characteristic upregulation of c-Kit expression (compared to its expression in control cells) was similar in Bcl11b-KO cells and Bcl11b-Zbtb16-DKO cells, Bcl11b-Id2-DKO cells had slightly lower expression of c-Kit (Fig. 6a ), which indicated that Id2 might have been involved in the abnormal elevation in c-Kit expression in Bcl11b-deficient cells. Interestingly, the upregulation of Zbtb16 itself in Bcl11b-KO cells was also lessened in Bcl11b-Id2-DKO cells ( Supplementary  Fig. 10 ), and this was confirmed at the protein level (PLZF) (Fig. 6b) . Thus, Id2 was involved in the upregulation of Zbtb16 expression in Bcl11b-deficient cells.
Most genes upregulated by deletion of Bcl11b (genes repressed by Bcl11b) showed overall similar responses in Bcl11b-KO, Bcl11b-Id2-DKO and Bcl11b-Zbtb16-DKO samples ( Fig. 6c and Supplementary ResouRce NaTuRe IMMuNoLogy Table 7) , which indicated that most of these 410 genes targeted for repression by Bcl11b did not depend on Id2 or PLZF for their expression (DEGs with FDR < 0.05, versus control (410 for Bcl11b-KO and 299 for either DKO); Fig. 6c and Supplementary Table 7 ). In contrast, among the 349 Bcl11b-dependent genes, the downregulation of many genes encoding molecules involved in the T cell program was ameliorated when Bcl11b was deleted together with Zbtb16 or especially with Id2 (Fig. 6c ). Double deletion of Id2 with Bcl11b provided protection to well over half of the Bcl11b-dependent genes (349 DEGs for Bcl11b-KO with FDR < 0.05 versus control, but only 72 for Bcl11b-Id2 DKO); Supplementary Table 7 ), which suggested that many of these genes were dependent on E proteins. KEGG (Kyoto Encyclopedia of Genes and Genomes) pathway analysis showed that deletion of Bcl11b preferentially upregulated genes encoding molecules in the 'cytokine-cytokine receptor interaction' and 'NK cell-mediated cytotoxicity' pathways, while it reduced expression of genes encoding molecules in the 'T cell receptor signaling' pathway. Although genes encoding molecules in the 'NK cell-mediated cytotoxicity' pathway were upregulated in Bcl11b-KO cells with or without Id2 or Zbtb16, there was much less upregulation of genes encoding molecules in the 'cytokine-cytokine receptor interaction' pathway in DKO samples, especially in Bcl11b-Id2-DKO samples, than in Bcl11b-KO samples. Double deletion also resulted in less inhibition of genes encoding molecules in the 'T cell receptor signaling' pathway ( Fig. 6d,e ). Thus, despite the weak overall effects of Id2 and PLZF on the gene-expression profiles of Bcl11b-deficient cells, they had effects specifically on the regulation of selective sets of genes encoding molecules related to the cytokine-cytokine receptor and TCR signaling pathways.
Double deletion of Id2 and Bcl11b did not always attenuate the effects of the loss of Bcl11b; for some targets repressed by Bcl11b, it amplified the effects of the disruption of Bcl11b (Supplementary Table 7 ). Certain genes that are preferentially expressed in TCRγ δ + intraepithelial lymphocytes, including Heyl and Cited4, as well as Bcl11a (which encodes a B cell-and progenitor-cell-associated regulatory molecule), were upregulated much more in Bcl11b-Id2-DKO samples than in Bcl11b-KO samples. These results indicated that Bcl11a, Heyl and Cited4 depended on positive regulation by E proteins even though they were also targets of repression by Bcl11b. Thus, the upregulation of Id2 could sometimes mediate but in other cases mask the full spectrum of the regulatory effects of Bcl11b.
Id2 and PLZF promote different alternative programs. Deletion of Bcl11b upregulates genes encoding molecules associated with various alternative fates, and it has not been clear whether this response represents one coordinated program or several programs. In confirmation of published reports 5,6,8 , we repeatedly detected more lineage marker-positive (Lin + ) cells among Bcl11b-deficient cells than among Bcl11b-sufficient (control) cells, especially cells expressing the activating NK cell receptor NK1.1 and the integrin subunit CD11c, even in T cell-developmental conditions (OP9-DL1 stroma; Supplementary Fig. 11a,b ) (compare with ref. 6 ). When Bcl11b-deficient cells were removed from Notch signaling on day 10 (transfer to OP9-Mig stromal cells), to allow the expression of factors involved in non-T cell fates, the frequency of Lin + cells rose over the next 4 d, with expression of NK1.1 and CD11c being most prominent ( Supplementary Fig. 11a,b) . Bcl11b-deficient pro-T cells had lower expression of NK1.1 or CD11c than that of mature NK cells or dendritic cells, respectively ( Supplementary  Fig. 11c ), but these markers indicated distinct altered regulatory states, and double-deletion experiments showed that Id2 and PLZF had distinct roles in these states. Both the frequency and the number of Lin + cells were significantly decreased among Bcl11b-Id2-DKO cells as compared to single Bcl11b-KO cells, which indicated that they depended on this E-protein antagonist. However, the abundance of Lin + cells was unexpectedly increased among Bcl11b-Zbtb16-DKO cells, both on OP9-DL1 stroma and on OP9-Mig stroma ( Fig. 7a and Supplementary Fig. 11d ,e; scales differ). Bcl11b-Id2-DKO cells generated fewer NK1.1 + cells than did single Bcl11b-KO cells, and Bcl11b-Zbtb16-DKO cells generated even fewer. In contrast, while the generation of CD11c + cells from Bcl11b-Id2-DKO cells was also reduced compared to their generation from single Bcl11b-KO cells, the generation of CD11c + cells from Bcl11b-Zbtb16-DKO cells was sharply enhanced ( Fig. 7a and Supplementary Fig. 11d,e ).
The effects of the single and double deletions reported above were cell intrinsic ( Fig. 7b and Supplementary Fig. 12a,b) . When we co-cultured Bcl11b-KO cells, Bcl11b-Id2-DKO cells, or Bcl11b-Zbtb16-DKO cells together with distinctly marked reference standard Bcl11b-KO cells (hNGFR) and reference standard cells transduced with empty vector (control cells; GFP), all in the same well ( Supplementary Fig. 12a ), the patterns of altered developmental phenotypes we observed were determined in a cell-autonomous way, only by the gene-perturbation history of the cells themselves ( Fig. 7b; quantification, Supplementary Fig. 12b ).
Thus, PLZF not only supported the generation of NK1.1 + cells but also restrained the expression of CD11c in Bcl11b-KO cells (Fig. 7a,c) , which forced the Bcl11b-KO phenotype normally closer to an NK cell-like profile. In turn, Id2 had stronger roles in other features of Bcl11b-deficient cells, including DN2a cell-like high expression of c-Kit, upregulated Zbtb16, increased expression of genes encoding cytokine and chemokine receptors, decreased expression of genes encoding molecules involved on the T cell program, and opening of the way for the generation of NK1.1 + and CD11c + cells (Fig. 7c,d) . The ability of Bcl11b to repress both Id2 and Zbtb16 is thus crucial for completion of the conventional commitment of T cells.
Discussion
The importance of Bcl11b for commitment to the T cell lineage has raised the question of how this factor works to promote and consolidate T cell identity 5, 6, 8 . Unlike the effects of the transcription factors Pax5 and EBF1 on the B cell lineage [51] [52] [53] [54] , the effects of Bcl11b on gene expression in T cells seem to be more limited and more related to immune system-activation thresholds ('adaptive' versus 'innatelike') than to T cell identity itself [6] [7] [8] 10, 12, 55 . A published study has shown that Bcl11b binds to numerous sites throughout the active topological domains of the genome in early T cells 18 , suggestive of a possible global organizational role for Bcl11b, but this leaves open its gene-specific regulatory role. Here we have used proteomics and genome-wide transcriptome and factor-binding analysis to demonstrate molecular mechanisms through which the binding of Bcl11b to specific genomic sites controlled target-gene expression during the commitment of T cells. We found that Bcl11b was able to repress target genes directly by nucleating complexes of co-repressors on the DNA at specific sites where they would not otherwise assemble. Such sites of Bcl11b-dependent recruitment or redirection of cofactors turned out to be a far better statistical discriminator of genes that Bcl11b actually controlled than was the binding of Bcl11b alone. At the same time, a substantial minority of the effects of Bcl11b were apparently indirect and were mediated through its repression of the regulatory factor-encoding genes Id2 and Zbtb16. Acute double deletion through the Cas9 system revealed that many effects of the deletion of Bcl11b were responses to the resultant increases in Id2 and/or PLZF. In particular, many genes expressed specifically by the T cell lineage, which apparently depend on Bcl11b for activation during commitment, in fact required Bcl11b largely for the suppression of Id2. Thus, in addition to its action on direct genomic targets, Bcl11b is an indirectly acting but critical member of the E protein-Id gene-regulatory network in pro-T cells during commitment.
The best statistical enrichment criteria available for the identification of loci that Bcl11b regulates, positively or negatively, turned ResouRce NaTuRe IMMuNoLogy out to be the presence of sites at which the assembly of chromatinmodifying complexes depended on the binding of Bcl11b. Such complexes often included Chd4, Mta2, Ring1b, LSD1 and Runx1; future work should also assess Brg1. Bcl11b-dependent nucleation of cofactor complexes was seen only at a small minority of Bcl11b sites and a minority of the sites for most of these cofactors. Deletion analysis of individual components of the chromatin-modification complexes showed that these components, stably expressed throughout commitment 56, 57 , were often important for the effects of Bcl11b, especially at loci that Bcl11b was repressing. Among the factors redeployed by Bcl11b, Runx1 was most potent for both the activation and the repression of target genes. Notably, the components that depended most on Bcl11b for recruitment differed from one genomic site to another. Although much remains to be learned about the mechanistic rules for transcriptional repression, this suggests that Bcl11b can interact with a variety of subunit assemblies individually, not only with pre-formed NuRD or PRC1 complexes as a whole.
New cofactor peaks also appeared in Bcl11b-KO cells at genomic sites never bound by Bcl11b in pro-T cells. These sites had a distinct motif-enrichment signature and were strongly associated with abnormal activation of genes that are normally repressed by Bcl11b. Thus, in addition to recruiting repression complexes, Bcl11b might also repress its target genes by preventing cofactors from assembling at other neighboring sites that could otherwise serve different, activating transcription factors. Gene regulation via redirection of limiting pools of cofactors, with or without direct DNA binding, is consistent with published findings of gene regulation mediated by the transcription factor PU.1 in early pro-T cells 46 . Therefore, gene regulation via the redeployment of partner factors could be a common mechanism used by transcription factors that have crucial roles in cell-fate decisions.
In summary, we have shown that the advent of Bcl11b expression during commitment re-centers T cell regulatory circuits in multiple ways. Bcl11b physically redirects the binding of Runx1 and chromatin-modulating complexes across the genome in site-specific ways that are highly concentrated around Bcl11b-regulated target genes. Such biochemical collaborations, especially with Runx1, are probably directly functional, especially for repression. At the same time, Bcl11b's repression of PLZF and Id2 blocks the implementation of at least two alternative programs that were regulated distinctly by these factors. Finally, its control of Id2 gives it a position of indirect power in a pro-T cell network in which the main direct effectors are E proteins and their own interaction partners. This network is particularly important for the expression of TCR-encoding genes and the stringent cell biology of β -selection and might well explain the importance of Bcl11b for these crucial milestones.
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Methods
Mice. C57BL/6 (B6) mice, B6.Cg-Tg(BCL2)25Wehi/J (Bcl2-tg) mice 58 and B6.Gt(ROSA)26 Sortm1.1(CAG-cas9*,-EGFP)Fezh /J (Cas9) mice 59 were purchased from the Jackson Laboratory. Vav1-iCre mice 35 (B6N.Cg-Commd10 Tg(Vav1-icre)A2Kio /J) were purchased from Jackson Laboratories, and Lck-Cre (Lck proximal promoter) mice developed by C. Wilson's group (B6.Cg-Tg(Lck-Cre)1Cwi N9 mice) 36 were purchased from Taconic Laboratories. The Cre activity reporter allele ROSA26R-eYFP 60 was also used in published studies of Bcl11b function 6, 7, 61 . Except for Vav1-iCre, which was maintained in heterozygous mice, the transgenes used here were bred to homozygosity alone or in combinations on the B6 background. Bcl11b fl/fl Rosa26-Cre-ERT2 mice 8 were derived from stock originally provided by P. Liu (Wellcome Sanger Institute) as previously described 7 and were maintained as a separate line. All animals were bred and maintained in the California Institute of Technology Laboratory Animal Facility, under specific pathogen-free conditions, and the protocol supporting animal breeding for this work was reviewed and approved by the Institute Animal Care and Use Committee of the California Institute of Technology.
Cells and cell culture. Thymuses were removed from 4-to 6-week-old Bcl11b +/+ , Bcl11b fl/+ and Bcl11b fl/fl ROSA26R-YFP mice with Vav1-iCre or Lck-Cre and singlecell suspensions were made. Lineage marker-positive (Lin + ) cells were depleted by staining with biotinylated antibodies (all from eBioscience except as otherwise indicated) to CD8α (53-6.7), TCRγ δ (GL3), TCRβ (Η 57597), Ter119 (Ter119), NK1.1 (PK136; BioLegend), Dx5 (Dx5), CD11c (N418) and CD11b (M1/70; BioLegend), after which the cells were incubated with streptavidin-coated magnetic beads and then passed through an LS magnetic column in accordance with the manufacturer's instructions (Miltenyi Biotec). Eluted DN cells were stained with anti-CD117 (c-Kit)-PE (2B8), anti-CD25-APCe780 (PC61.5) and anti-CD44-e450 (IM7), and YFP + CD25 + and YFP -CD25 + cells were sorted by a FACSAria (BD Bioscience). For flow cytometry, eluted DN cells were stained as above for purification and were analyzed with FlowJo software (Tree Star).
Scid.adh.2c2 cells 38 were cultured in RPMI1640 with 10% FBS (FBS, Sigma-Aldrich), sodium pyruvate (Gibco), non-essential amino acids (Gibco), Pen-Strep-Glutamine (Gibco) and 50 μ M β -mercaptoethanol (Sigma-Aldrich).
For in vitro differentiation of pro-T cells, bone marrow (BM) hematopoietic progenitor cells were used for input. BM was removed from the femurs and tibiae of 2-to 3-month-old mice. Suspensions of BM cells were prepared and stained for lineage markers using biotin-conjugated antibodies to lineage markers (CD11b (identified above), CD11c (identified above), Gr1 (RB6-8C5; eBioscience), TER-119 (identified above), NK1.1 (identified above), CD19 (eBio-1D3; eBioscience), CD3ε (145-2C11; eBioscience) and B220 (RA3-6B2; eBioscience)), then were incubated with streptavidin-coated magnetic beads (Miltenyi Biotec) and passed through a magnetic column (Miltenyi Biotec). Then, Lin -Sca1 + c-Kit + (LSK) cells were sorted on a FACSAria (BD Bioscience). LSK cells were cultured on OP9-DL1 monolayers in OP9 medium (α -MEM, 20% FBS, 50 μ M β -mercaptoethanol and Pen-Step-Glutamine) supplemented with 10 ng/ml of IL-7 (Pepro Tech) and 10 ng/ml of Flt3L (Pepro Tech). On day 7, cultured cells were disaggregated, filtered through 40-μ m nylon mesh and re-cultured on new OP9-DL1 monolayers with medium containing 5 ng/ml of IL-7 and 5 ng/ml of Flt3L. For cultures that were continued for longer times, cells were passaged onto fresh OP9-DL1 monolayers at day 10 and were maintained up to day 14 in 1 ng/ml each of IL-7 and Flt3L.
In samples that were tested for alterations to developmental lineage, the final passage at day 10 was either onto fresh OP9-DL1 monolayers or onto OP9-control monolayers without the Notch ligand DL1 (OP9-Mig; called 'OP9control' in ref. 39 ).
Acute deletion of Bcl11b in T cell-development cultures.
We used two methods to delete Bcl11b acutely in vitro, at a known time point and developmental stage, for the perturbation experiments in this study.
To generate sufficient numbers of control cells and cells in which Bcl11b was deleted for ChIP-seq analysis, we used acute deletion of loxP-flanked Bcl11b in cells with Cre-ERT2 activated by 4-OH tamoxifen. BM-derived precursor cells from control Bcl11b +/+ Cre-ERT2 mice and from Bcl11b fl/fl Cre-ERT2 mice were cultured in parallel on OP9-DL1 stroma to day 7 as described above. Upon re-culture, both control samples and experimental samples were supplemented with 120 nM of 4-OH tamoxifen (4-OHT, Sigma-Aldrich). Thus, both control samples and experimental samples contained the transgene encoding Cre-ERT2, were exposed to 4-OHT and were subject to Cre activity. 2 d later, 4-OHT was removed and cells were cultured for an additional 5 d (to day 14 overall) on fresh OP9-DL1 stroma with 1 ng/ml of IL-7, 1 ng/ml of Flt3L ( Supplementary Fig. 4c ). They were then harvested for further analysis and preparation of DNA for ChIP.
RNA-expression responses to real-time perturbation were measured using Cas9 plus sgRNA for acute mutational disruption of Bcl11b, Runx1, Id2, Zbtb16 and/or genes encoding cofactors. This method was superior to the Cre-ERT2 method for comparison of RNA-seq analyses, because all perturbations could be carried out on the identical genetic background and the potentially toxic effects of 4-OHT with Cre 62 could be eliminated. To generate input cells, Cas9 mice were first bred to Bcl2-tg mice to generate mice heterozygous for both transgenes. BM cells from these Cas9;Bcl2-tg mice (called 'Cas9-Bcl2 mice' here) were then used to seed in vitro differentiation cultures as above. At day 7, the cells were transduced with retroviral vectors encoding a fluorescent reporter (CFP or hNGFR) and the appropriate sgRNAs as detailed below and then were returned to OP9-DL1 culture. Cells were analyzed after another 7 d of culture (to day 14 overall) or as indicated for specific experiments.
Flow cytometry. For staining of BM cells transduced with sgRNA, antibodies to cell-surface CD45 (3O-F11; eBioscience), c-Kit (2B8; eBioscience), CD25 (PC61.5; eBioscience) and a biotin-conjugated lineage cocktail (anti-CD8α , anti-CD11b, anti-CD11c, anti-Gr1, anti-TER-119, anti-NK1.1, anti-CD19, anti-TCRβ and anti-TCRγ δ ) were used for staining. Prior to cell surface staining cells were treated with supernatant of 2.4G2 cells to block Fc receptors. Where indicated, intracellular staining using the BD cytofix/cytoperm Kit (BD Bioscience) was carried out with anti-PLZF AlexaFluor 647 (BD Bioscience). All of the cells were analyzed using a flow cytometer, MacsQuant 10 (Miltenyi) with FlowJo software (Tree Star).
Cloning. cDNA encoding Myc-Flag-tagged Bcl11b was inserted into a multicloning site of the pMxs-IRES-GFP vector. The Cas9-GFP expression vector (pQCXIN-EF1a-mNeonGreen-P2ACas9) and sgRNA-CFP expression vector (E42-dTet-CFP, in which mTurquoise is the CFP reporter) were described previously 46 . 19-residue sgRNAs were designed using the CHOPCHOP web tool (https://chopchop.rc.fas.harvard.edu/) and were inserted into the empty sgRNA expression vector by PCR-based insertion (sgRNA sequences, Supplementary  Table 8 ). Three sgRNA expression vectors were generated for each gene as described above, and pooled retroviral plasmids were used to make retroviral supernatant.
Retroviral infection.
The methods used to generate the viral supernatant and for infection were described previously 63 . Lin -BM cells were cultured for 7 d and then were disaggregated, filtered through 40-μ m nylon mesh, transferred onto RetroNectin-coated virus-bound plates and cultured in OP9 medium supplemented with 5 ng/ml of IL-7, 5 ng/ml of Flt3L and 10 ng/ml of SCF. Infected cells were cultured for an additional 7 d on OP9-DL1 stroma before being subjected to further analysis. For sorting, cells were stained with anti-CD45 and anti-CD25 and a biotin-conjugated lineage cocktail (antibodies to CD8α , CD11b, CD11c, Gr1, TER-119, NK1.1, CD19, TCRβ , TCRγ δ ) (all antibodies identified above), and were sorted for infected CD25 + cells (Lin -CD45 + CD25 + CFP + ). Two-step affinity purification of Bcl11b complexes from the DN3-like cell line Scid.adh.2c2. Scid.adh.2c2 cells 38, 39 were infected with either mock control retrovirus (pMxs-IRES-GFP) or retrovirus encoding Myc-Flag-Bcl11b. 3 d after infection, Scid.adh.2c2 cells infected with the Myc-Flag-tagged Bcl11bencoding retrovirus were solubilized with a protease inhibitor-containing immunoprecipitation buffer (50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 10% glycerol, 0.1% Tween, 1 mM EDTA, 10 mM NaF, 1 mM DTT and a protease inhibitor cocktail (Roche Applied Science)), then were lysed on ice for 30 min with gentle shaking and sonicated on a Misonix S-4000 sonicator (Qsonica) for three cycles, amplitude 20 for 30 s, followed by 30 s of 'rest' . We did not add benzonase or ethidium bromide to exclude DNA-or RNA-mediated interactions because we were interested in the functionally relevant complexes that Bcl11b forms as it is working on the DNA. The insoluble materials were removed by centrifugation, and immunoprecipitation with anti-Flag M2 agarose (Sigma-Aldrich) was performed overnight at 4 °C. Immunocomplexes were eluted from the agarose by 3xFlag peptide (Sigma-Aldrich), and the eluted Bcl11b complexes were subjected second immunoprecipitation with anti-Myc gel (MBL). Immunocomplexes were eluted from the gel with Myc peptide (MBL) and were separated by SDS-PAGE. Bands were excised from the gel and subjected to mass spectrometry to identify corresponding proteins. The gel pieces were washed twice with 100 mM bicarbonate in acetonitrile, and the proteins were digested with trypsin. After 0.1% formic acid was added to the supernatant, the peptides were analyzed by liquid chromatography-tandem mass spectrometry with an Advance UHPLC (Bruker) and an Orbitrap Velos Pro Mass Spectrometer (Thermo Fisher Scientific). The resulting tandem mass spectrometry dataset was analyzed with the Mascot software program (Matrix Science).
Gene Ontology and KEGG pathway analysis. Gene Ontology (GO) and (KEGG (Kyoto Encyclopedia of Genes and Genomes) pathway annotation was performed using the DAVID analysis tool (https://david.ncifcrf.gov/).
Immunoprecipitation and immunoblot analysis.
Protein extracts from Scid. adh.2c2 cells infected to express Myc-Flag-tagged Bcl11b were subjected to immunoprecipitation as described previously 43 . Nuclear extracts were prepared using NE-PER Nuclear and Cytoplasmic Extraction Reagents (Thermo Scientific). The antibodies used for the immunoblot analyses were anti-Chd4 (A301-081A, Bethyl), anti-Mta2 (sc-9447, Santa Cruz Biotechnology), anti-Hdac2 (ab12169, Abcam), anti-Rest (12C11-1B11, Caltech Protein Expression Center), anti-Ring1b (A302-869A, Bethyl), anti-LSD1 (ab17721, Abcam), anti-Runx1 (ab23980, Abcam), anti-Bcl11b (ab18465, Abcam), anti-lamin B (sc-6217, Santa Cruz Biotechnology) and anti-Myc (My3, MBL).
nature research | reporting summary
March 2018
Methodology Sample preparation Thymuses from 4-6wk old Bcl11b+/+, Bcl11bfl/+, and Bcl11bfl/fl ROSA26R-YFP mice with Vav1-iCre or Lck-Cre were removed, and single-cell suspensions were made. Lineage-positive cells were depleted by staining with biotinylated antibodies to CD8α (53-6.7), TCRγδ (GL3), TCRβ (Η57597), Ter119 (Ter119), NK1.1 (PK136), Dx5, and CD11c (N418), CD11b (M1/70), after which the cells were incubated with streptavidin-coated magnetic beads and then passed through an LS magnetic column in accordance with the manufacturer's instructions (Miltenyi Biotec). For in vitro differentiation of pro-T cells, bone marrow hematopoietic progenitors were used for input. Bone marrow (BM) was removed from the femurs and tibiae of 2-3 month-old mice. Suspensions of BM cells were prepared and stained for lineage markers using biotin-conjugated lineage antibodies (CD11b, CD11c, Gr1, TER-119, NK1.1, CD19, CD3ε, B220), then incubated with streptavidin-coated magnetic beads (Miltenyi Biotec), and passed through a magnetic column (Miltenyi Biotec). Then, Lin-Sca1+Kit+ (LSK) cells were sorted on a FACSAria (BD Bioscience). LSK cells were cultured on OP9-DL1 monolayers using OP9 medium (α-MEM, 20% FBS, 50 μM β-mercaptoethanol, Pen-Step-Glutamine) supplemented with 10 ng/ml of IL-7 (Pepro Tech Inc) and 10 ng/ml of Flt3L (Pepro Tech Inc). On day 7, cultured cells were disaggregated, filtered through 40-μm nylon mesh, and re-cultured on new OP9-DL1 monolayers with medium containing 5 ng/ml of IL-7 and 5 ng/ml of Flt3L. In cultures that were continued for longer times, cells were passaged onto fresh OP9-DL1 monolayers at day 10 and maintained up to day 14 in 1 ng/ ml each of IL-7 and Flt3L. Cell population abundance The abundance of the post-sort fractions were higher than 98%.
Instrument
Gating strategy
Doublets were excluded using forward light-scatter gating followed by gating on lymphocytes based on FSC/SSC. Dead cells were excluded by gating on 7AAD negative cells. These cells were further gated as indicated in Supplementary Figures.
Tick this box to confirm that a figure exemplifying the gating strategy is provided in the Supplementary Information.
